Identifying genetic markers for splenic lymphoma
Genomic biomarkers of splenic lymphoma
This study is looking for specific genetic markers in the blood of people with splenic marginal zone lymphoma (SMZL) to help doctors diagnose the cancer earlier and more accurately, so patients can get the right treatment without needing surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10994066 on NIH RePORTER |
What this research studies
This research focuses on splenic marginal zone lymphoma (SMZL), a type of cancer affecting the spleen. It aims to develop reliable genomic biomarkers that can be detected in peripheral blood, allowing for earlier and more accurate diagnosis of the disease. By utilizing whole genome and exome sequencing, the study seeks to identify specific genetic alterations associated with SMZL, which could improve diagnostic accuracy and reduce the need for invasive procedures like splenectomy. Patients will be monitored for these biomarkers to facilitate timely intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with or suspected to have splenic marginal zone lymphoma.
Not a fit: Patients with other types of lymphoma or those who do not have any splenic involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better treatment options for patients with splenic lymphoma.
How similar studies have performed: Previous research has shown promise in using genomic biomarkers for cancer diagnosis, indicating potential success for this approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Elenitoba-Johnson, Kojo S. J. — Sloan-Kettering Inst Can Research
- Study coordinator: Elenitoba-Johnson, Kojo S. J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.